The interplay between NOX inhibition and NF-κB suppression in endothelial cells highlights the interaction between NOX and NF-κB signaling (Park et al., 2016), which has been implicated in endothelial dysfunction caused by high-dose intravenous iron supplementation. The gene discussed is NFKB1; the disease is endothelial dysfunction.